該雜志國(guó)際簡(jiǎn)稱:EXPERT OPIN DRUG DEL,是由出版商Taylor and Francis Ltd.出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以PHARMACOLOGY & PHARMACY研究為重點(diǎn),主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。
《Expert Opinion On Drug Delivery》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊,中文名稱藥物輸送專家意見(jiàn),本刊主要出版、報(bào)道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為5,最新CiteScore 指數(shù)為11.1。
本刊近期中國(guó)學(xué)者發(fā)表的論文主要有:
The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)(2) nanoparticles facilitating Cu accumulation in the tumor
Expert Opinion on Drug Delivery (ISSN 1742-5247 [print], 1744-7593 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.